These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2277 related items for PubMed ID: 35331183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma.
    Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS.
    Cancer Manag Res; 2021; 13():6451-6471. PubMed ID: 34429653
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.
    Huang J, Song J, Li X, Liu S, Huang W, Shen Z, Cheng Y, Kou S, Gao Z, Tian Y, Hu J.
    BMC Med Genomics; 2022 Jul 25; 15(1):164. PubMed ID: 35879790
    [Abstract] [Full Text] [Related]

  • 6. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K, Wang F, Li K, Peng G, Yang H, Xu H, Xiang Y, Sun H.
    Technol Cancer Res Treat; 2022 Jul 25; 21():15330338221085354. PubMed ID: 35422168
    [Abstract] [Full Text] [Related]

  • 7. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
    Chen Z, Zhang W, Yan Z, Zhang M.
    Cancer Med; 2023 Jan 25; 12(1):760-788. PubMed ID: 35668574
    [Abstract] [Full Text] [Related]

  • 8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X.
    Front Immunol; 2022 Jan 25; 13():1056932. PubMed ID: 36479114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y, Qu H.
    BMC Cancer; 2022 Jun 08; 22(1):633. PubMed ID: 35676619
    [Abstract] [Full Text] [Related]

  • 11. The identification of N6-methyladenosine-related miRNAs predictive of hepatocellular carcinoma prognosis and immunotherapy efficacy.
    Zou R, Liu Y, Qiu S, Lu Y, Chen Y, Yu H, Zhu H, Zhu W, Zhu L, Feng J, Han J.
    Cancer Biomark; 2023 Jun 08; 38(4):551-566. PubMed ID: 38007640
    [Abstract] [Full Text] [Related]

  • 12. Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.
    Jin Y, Wang Z, He D, Zhu Y, Hu X, Gong L, Xiao M, Chen X, Cheng Y, Cao K.
    Front Immunol; 2021 Jun 08; 12():637933. PubMed ID: 33746977
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM, Li X, Yang P, Geng WB, Wang XY.
    BMC Gastroenterol; 2022 Feb 21; 22(1):76. PubMed ID: 35189810
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 114.